CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenue	$ 1,895.6	$ 1,765.9	$ 1,611.3
Cost of revenue	995.6	949.9	866.0
Gross profit	900.0	816.0	745.3
Operating expenses:
Selling, general and administrative	444.7	415.2	389.8
Research and development	173.4	161.6	147.9
Other charges, net	19.5	19.7	25.8
Total operating expenses	637.6	596.5	563.5
Operating income	262.4	219.5	181.8
Interest and other income (expense), net	(17.7)	(21.7)	(4.2)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	244.7	197.8	177.6
Income tax provision	63.7	117.5	23.1
Consolidated net income	181.0	80.3	154.5
Net income attributable to noncontrolling interest in consolidated subsidiaries	1.3	1.7	0.9
Net income attributable to Bruker Corporation	$ 179.7	$ 78.6	$ 153.6
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 1.15	$ 0.50	$ 0.95
Diluted (in dollars per share)	$ 1.14	$ 0.49	$ 0.95
Weighted average common shares outstanding:
Basic (in shares)	156.2	158.1	161.4
Diluted (in shares)	157.2	159.1	162.2
Consolidated net income	$ 181.0	$ 80.3	$ 154.5
Foreign currency translation adjustments	(25.5)	97.1	(27.6)
Pension liability adjustments (net of tax of $3.8 million, $2.9 million and $2.1 million, respectively)	15.3	6.5	(4.4)
Net comprehensive income	170.8	183.9	122.5
Less: Comprehensive income attributable to noncontrolling interests	1.1	2.4	0.6
Comprehensive income attributable to Bruker Corporation	$ 169.7	$ 181.5	$ 121.9
Dividend declared per common share (in dollars per share)	$ 0.16	$ 0.16	$ 0.16
Product
Revenue	$ 1,576.6	$ 1,479.5	$ 1,345.4
Cost of revenue	801.1	787.7	711.4
Service
Revenue	311.7	278.2	254.7
Cost of revenue	193.4	160.8	150.0
Other
Revenue	7.3	8.2	11.2
Cost of revenue	$ 1.1	$ 1.4	$ 4.6